Insider selling
Traded Sep 2 · filed 1 day laterNot reported under a pre-arranged trading plan
Since the trade −59.5% · S&P 500 −9.8% · to Nov 20
Autolus Therapeutics's U.S. CCO & Country Gen Manager sold $16K of Autolus Therapeutics shares. The filing does not indicate a pre-arranged trading plan.